Little information about fertility preservation is provided for cancer patients: A survey of oncologists' knowledge, attitude and current practice.
Adult
Age Factors
Attitude of Health Personnel
Clinical Competence
Cross-Sectional Studies
Cryopreservation
Female
Fertility Preservation
Fertilization in Vitro
Gonadotropin-Releasing Hormone
/ therapeutic use
Humans
Iran
Male
Middle Aged
Neoplasms
Oncologists
Oocyte Retrieval
Patient Education as Topic
Practice Patterns, Physicians'
Semen Preservation
Surveys and Questionnaires
cancer
fertility preservation
infertility
oncofertility
oncologists
Journal
European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
15
08
2017
revised:
20
06
2018
accepted:
02
09
2018
pubmed:
14
11
2018
medline:
15
5
2019
entrez:
14
11
2018
Statut:
ppublish
Résumé
The objective of this survey was to explore the knowledge, attitude and current practice of Iranian oncologists about fertility preservation (FP) services provided to cancer patients. Oncologists who completed this survey were a convenience sample of 103 specialists in radiation oncology and haematology who attended large national and international congresses and symposia across Iran. A 23-item self-administered questionnaire included questions on knowledge, attitudes and practice. The most well known of the FP methods among Iranian oncologists were gonadotropin-releasing hormone therapy and sperm cryopreservation, with scores of 2.77 (1.10) and 2.64 (1.00) respectively. These scores were above the median value of 2.5 on a 4-point Likert scale, in contrast to a mean knowledge score across all the FP options of 2.25 (0.71). With regard to attitudes, age was the most important reason for discussing FP with patients, mean score 3.75 (0.54), while heredity was the least important, mean score 2.98 (0.87). In terms of practice, most oncologists did not provide their patients with written information about FP. However, 74 (72.5%) said they referred cancer patients on to reproductive specialists. This sample of Iranian oncologists would benefit from more information on FP methods and prevent loss of fertility among cancer patients.
Substances chimiques
Gonadotropin-Releasing Hormone
33515-09-2
Types de publication
Journal Article
Langues
eng
Pagination
e12947Informations de copyright
© 2018 John Wiley & Sons Ltd.